Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 1, 2010, Pages 106-112

  Herrera Solís, Andrea ^a   Vásquez, Khalil Guzmán ^a   Prospéro García, Oscar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anandamide; Endocannabinoids; Oleamide; REM sleep; Sleep; Subchronic

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; OLEAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG WITHDRAWAL; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REM SLEEP; SLEEP WAKING CYCLE; WITHDRAWAL SYNDROME;

ANIMALS; ARACHIDONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; OLEIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; SLEEP, REM;

RATTUS;

EID: 77249144912     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.12.014     Document Type: Article

References (26)

1. Axelrod J., Felder C.C. Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem Res 1998, 23:575-581.
2. Basile A.S., Hanus L., Mendelson W.B. Characterization of the hypnotic properties of oleamide. Neuroreport 1999, 10:947-951.
3. Bortolato M., Campolongo P., Mangieri R.A., Scattoni M.L., Frau R., Trezza V., et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 2006, 31:2652-2659.
4. Costa B., Giagnoni G., Colleoni M. Precipitated and spontaneous withdrawal in rats tolerant to anandamide. Psychopharmacol (Berl) 2000, 149:121-128.
5. Cravatt B.F., Prospéro-García O., Siuzdak G., et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995, 268:1506-1509.
6. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384:83-87.
7. Crawley J.N., Corwin R.L., Robinson J.K., Felder C.C., Devane W.A., Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 1993, 46:967-972.
8. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., et al. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 2001, 299:332-342.
9. Huitrón-Reséndiz S., Gombart L., Cravatt B.F., Henriksen S.J. Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol 2001, 172:235-243.
10. Huitrón-Reséndiz S., Sanchez-Alavez M., Wills D.N., Cravatt B.F., Henriksen S.J. Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. Sleep 2004, 27:857-865.
11. Laposky A.D., Homanics G.E., Basile A., Mendelson W.B. Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport 2001, 12:4143-4147.
12. Leggett J.D., Aspley S., Beckett S.R., D'Antona A.M., Kendall D.A., Kendall D.A. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 2004, 141:253-262.
13. Maione S., Bisogno T., de Novellis V., et al. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J Pharmacol Exp Ther 2006, 316:969-982.
14. Martínez-González D., Bonilla-Jaime H., Morales-Otal A., Henriksen SJ Velázquez-Moctezuma J., Prospéro-García O. Oleamide and anandamide effects on food intake and sexual behavior of rats. Neurosci Lett 2004, 24(364):1-6.
15. Mendelson W.B., Basile A.S. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport 1999, 10:3237-3239.
16. Mendelson W.B., Basile A.S. The hypnotic actions of the fatty acid amide, oleamide. Neuropsychopharmacol 2001, 25:36-39.
17. Murillo-Rodríguez E., Sánchez-Alavez M., Navarro L., Martínez-González D., Drucker-Colín R., Prospéro-García O. Anandamide modulates sleep and memory in rats. Brain Res 1998, 812:270-274.
18. Murillo-Rodríguez E., Cabeza R., Méndez-Díaz M., Navarro L., Prospéro-García O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 2001, 12:2131-2136.
19. Navarro L., Martínez-Vargas M., Murillo-Rodríguez E., Landa A., Méndez-Díaz M., Prospéro-García O. Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. Neuroscience 2003, 120:855-859.
20. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Raven Press, New York.
21. Prospéro-García O., Méndez-Díaz M. The role of neuropeptides in sleep modulation. Drug News Perspect 2004, 17:518-522.
22. Romero J., García L., Fernández-Ruiz J.J., Cebeira M., Ramos J.A. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 1995, 51:731-737.
23. Rueda-Orozco P., Soria-Gómez E., Montes-Rodríguez C.J., Martínez-Vargas M., Galicia O., Navarro L., et al. A potential function of endocannabinoids in the selection of a navigation strategy by rats. Psychopharmacol 2008, 198:565-576.
24. Rueda-Orozco P., Montes-Rodríguez C.J., Soria-Gómez E., Méndez-Díaz M., Prospéro-García O. Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. Neuropharmacol 2008, 55:55-62.
25. Santucci V., Storme J.J., Soubrié P., Le Fur G. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 1996, 58:103-110.
26. Viveros M.P., Marco E.M., File S.E. Endocannabinoid system and stress and anxiety response. Pharmacol Biochem Behav 2005, 81:331-342.